Media2017-10-24T20:47:01+00:00

Forge Therapeutics and Evotec present efficacy data for LpxC Inhibitor in urinary tract, lung, thigh, and abdominal infection models at ASM ESCMID 2017

San Diego, California, September 7, 2017 – Forge Therapeutics, Inc., (Forge) and its strategic alliance [...]

September 7th, 2017|

Forge Therapeutics and Evotec to present preclinical data on novel antibiotic program at 2017 ASM/ESCMID Conference

San Diego, California, August 29, 2017 – Forge Therapeutics, Inc., (Forge) and its strategic alliance [...]

August 29th, 2017|

Forge Therapeutics forms scientific advisory board with world renowned antibiotic and drug development experts

San Diego, California, July 26, 2017 – Forge Therapeutics, Inc., (Forge), a biotechnology company discovering [...]

July 25th, 2017|

Categories

Archives

Recent Tweets